Bausch Health Announces 2024 Annual Meeting of Shareholder Results [Yahoo! Finance]
Bausch + Lomb Co. (NYSE: BLCO) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $18.00 price target on the stock, up previously from $16.00.
Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript [Yahoo! Finance]
Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall [Yahoo! Finance]
Why Bausch Health Companies Stock Dived by More Than 7% Today [Yahoo! Finance]